Home › Funds › Fidato Wealth LLC › REGN
Fidato Wealth LLC position in REGN
REGENERON PHARMACEUTICALS · Health Care
Fidato Wealth LLC reported holding 300 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$227K, representing 0.13% of its reported portfolio and ranking #27 among its reported holdings. Fidato Wealth LLC has disclosed REGN holdings in 3 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-10-14 · Source: SEC EDGAR Form 13F-HR
How Fidato Wealth LLC's REGN position evolved
Fidato Wealth LLC first disclosed a stake in REGN in Q4 2024 at 350 shares (US$249K). Across 3 filings, Fidato Wealth LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 300 shares valued at US$227K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 350 | $249.32K | New |
| Q1 2025 | 352 | $223.25K | Add |
| Q3 2026 | 300 | $227.48K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About REGN and 13F data
REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 31 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), LOOMIS SAYLES & CO L P (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding REGN
- Dodge & Cox 4.87M sh · $3.04B · Q2 2026
- DODGE & COX 4.87M sh · $3.04B · Q2 2026
- LOOMIS SAYLES & CO L P 1.86M sh · $1.16B · Q2 2026
More on Fidato Wealth LLC
FAQ
How long has Fidato Wealth LLC held REGN?
Fidato Wealth LLC has disclosed REGN holdings in 3 of the last 8 reported quarters, going back to Q4 2024.
What is Fidato Wealth LLC's current position in REGN?
As of Q3 2026, Fidato Wealth LLC holds 300 shares of REGN (REGENERON PHARMACEUTICALS), valued at $227.48K, representing 0.13% of its reported portfolio and ranking #27.
Has Fidato Wealth LLC been buying or selling REGN?
In the latest 13F filing (Q3 2026), Fidato Wealth LLC newly opened its position in REGN.
Which other funds hold REGN?
Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, LOOMIS SAYLES & CO L P, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.